A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics

Clinical Proteomics

Kayla Hickey¹  Stefan E Pambuccian²  Melissa A Geller³  Kristin LM Boylan¹  Timothy J Griffin⁴  Somaieh Afiuni-Zadeh¹  Amy PN Skubitz¹ 

[1] Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, USADepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, USADepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, USA;Department of Pathology, Loyola University Medical Center, Chicago, USADepartment of Pathology, Loyola University Medical Center, Chicago, USADepartment of Pathology, Loyola University Medical Center, Chicago, USA;Department of Obstetrics, Gynecology, and Women’s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, USADepartment of Obstetrics, Gynecology, and Women’s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, USADepartment of Obstetrics, Gynecology, and Women’s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, USA;Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, USADepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, USADepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, USA

关键词: Mass spectrometry;    Proteomics;    Pap test;    Biomarker discovery;   

DOI  :  10.1186/1559-0275-11-30

来源: Humana Press Inc

【 摘 要 】

Abstract

Background

The proteomic analysis of body fluids is a growing technology for the identification of protein biomarkers of disease. Given that Papanicolaou tests (Pap tests) are routinely performed on over 30 million women annually in the U.S. to screen for cervical cancer, we examined the residual Pap test fluid as a source of protein for analysis by mass spectrometry (MS). In the liquid-based Pap test, cervical cells are collected from the ectocervix and placed into an alcohol-based fixative prior to staining and pathologic examination. We hypothesized that proteins shed by cells of the female genital tract can be detected in the Pap test fixative by MS-based proteomic techniques. We examined the feasibility of using residual fluid from discarded Pap tests with cytologically “normal” results to optimize sample preparation for MS analysis. The protein composition of the cell-free Pap test fluid was determined by silver staining of sodium dodecyl sulfate -polyacrylamide gels, and the abundance of serum proteins was examined by Western immunoblot using an antibody against human serum albumin. Both pooled and individual samples were trypsin digested and analyzed by two-dimensional MS/MS. Proteins were identified by searching against the Human Uniprot database, and characterized for localization, function and relative abundance.

Results

The average volume of the residual Pap test fluid was 1.5 ml and the average protein concentration was 0.14 mg/ml. By Western immunoblot we showed that the amount of albumin in each sample was significantly reduced compared to normal serum. By MS/MS, we identified 714 unique proteins in pooled Pap test samples and an average of 431 proteins in individual samples. About 40% of the proteins identified were extracellular or localized to the plasma membrane. Almost 20% of the proteins identified were involved in immunity and defense, characteristic of the healthy cervical-vaginal proteome. By merging the protein sets from the individual and pooled Pap test samples, we created a “Normal Pap test Core Proteome” consisting of 153 proteins.

Conclusions

Residual Pap test fluid contains a sufficient amount of protein for analysis by MS and represents a valuable biospecimen source for the identification of protein biomarkers for gynecological diseases.

【 授权许可】

Unknown